<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03445936</url>
  </required_header>
  <id_info>
    <org_study_id>317/2017</org_study_id>
    <nct_id>NCT03445936</nct_id>
  </id_info>
  <brief_title>PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy Closure</brief_title>
  <official_title>PRELOOP Trial: Synthetic Versus Biological Mesh for Prevention of Incisional Hernia After Loop-ileostomy Closure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares a synthetic mesh and biological implant in prevention of incisional
      hernia after loop-ileostomy closure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Incisional hernia after loop-ileostomy closure may be an underestimated problem. Research on
      both biological and synthetic mesh in this context is scarce and no randomized controlled
      trials comparing meshes exist.

      The aim of this study is to compare Parietene Macro and Permacol in prevention of incisional
      site hernia after temporary loop-ileostomy reversal after anterior resection and TME for
      rectal cancer.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 13, 2018</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a prospective randomized controlled multicenter trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Subject is blinded of the mesh used. Outcome at 10 month follow-up is assessed by surgeon who was not involved in the operation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>30 days</time_frame>
    <description>The incidence of surgical site infections at 30 days follow up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incisional hernia</measure>
    <time_frame>10 months</time_frame>
    <description>Incidence of incisional hernia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications classified by Clavien-Dindo classification</measure>
    <time_frame>30 days</time_frame>
    <description>Clavien-Dindo I-V complications at 30 days follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-operation rate</measure>
    <time_frame>5 years</time_frame>
    <description>Demand for re-operations related to mesh or complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>30 days</time_frame>
    <description>Time (min) needed for operation and application of mesh/implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>30 days</time_frame>
    <description>Length of stay at the hospital after the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>5 years</time_frame>
    <description>Quality of life after the operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hernia</measure>
    <time_frame>5 years</time_frame>
    <description>Incidence of incisional hernia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost analysis</measure>
    <time_frame>5 years</time_frame>
    <description>Analysis of costs to both individual and community</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Rectum Cancer</condition>
  <arm_group>
    <arm_group_label>Parietene Macro</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Parietene Macro is a macroporous synthetic mesh used in retro muscular sublay position to prevent incisional hernia after loop-ileostomy closure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Permacol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Permacol is a acellular porcine dermal implant used in retro muscular sublay position to prevent incisional hernia after loop-ileostomy closure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Parietene Macro</intervention_name>
    <description>Parietene Macro is placed and sutured on retro muscular space on closed posterior rectus sheath to prevent incisional hernia.</description>
    <arm_group_label>Parietene Macro</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Permacol</intervention_name>
    <description>Permacol biologic implant is placed and sutured on retro muscular space on closed posterior rectus sheath to prevent incisional hernia.</description>
    <arm_group_label>Permacol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Anterior resection and TME with temporary loop-ileostomy for rectal carcinoma without
             any adjuvant oncological treatment

          -  18 years or older

          -  Patient has a life expectancy of at least 12 months.

          -  Patient signs the Informed consent and agrees to attend all study visits

          -  Loop-ileostomy closure within 2-4 months after the anterior resection

        Exclusion Criteria:

          -  Patient with a comorbid illness or condition that would precluded the use of surgery
             (ASA 4-5).

          -  Patients with concurrent or previous malignant tumors within 5 years before study
             enrollment

          -  Patients with T4b tumors which imposed a multi-organ resection

          -  Patients treated with postoperative adjuvant chemotherapy

          -  Patient undergone emergency procedures

          -  Primary rectal surgery along with major concomitant procedures (e.g. hepatectomies,
             other intestinal resections).

          -  Metastatic disease with life expectancy of less than 12 months

          -  Pregnancy or suspected pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisa Mäkäräinen-Uhlbäck</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisa Makarainen-Uhlback</last_name>
    <phone>+35883152282</phone>
    <email>elisa.makarainen-uhlback@ppshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tero Rautio</last_name>
    <phone>+35883152817</phone>
    <email>tero.rautio@ppshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jyvaskyla Central Hospital</name>
      <address>
        <city>Jyvaskyla</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Kairaluoma</last_name>
      <email>Matti.kairaluoma@ksshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne Fagerstrom</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisa Makarainen-Uhlback</last_name>
      <phone>+35883152282</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seinajoki Central Hospital</name>
      <address>
        <city>Seinäjoki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarja Pinta, Ph.D.</last_name>
      <email>tarja.pinta@epshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sannamari Kotaluoto</last_name>
      <email>sannamari.kotaluoto@pshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jukka Karvonen</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2018</study_first_submitted>
  <study_first_submitted_qc>February 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2018</study_first_posted>
  <last_update_submitted>April 29, 2018</last_update_submitted>
  <last_update_submitted_qc>April 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oulu</investigator_affiliation>
    <investigator_full_name>Elisa Makarainen-Uhlback</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>loop-ileostomy reversal</keyword>
  <keyword>hernia prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Incisional Hernia</mesh_term>
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

